0001213900-22-013589.txt : 20220318 0001213900-22-013589.hdr.sgml : 20220318 20220318161544 ACCESSION NUMBER: 0001213900-22-013589 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220316 FILED AS OF DATE: 20220318 DATE AS OF CHANGE: 20220318 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sarnoff David CENTRAL INDEX KEY: 0001751105 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38803 FILM NUMBER: 22752721 MAIL ADDRESS: STREET 1: 1 ROCKEFELLER PLAZA, SUITE 1039 CITY: NEW YORK STATE: NY ZIP: 10020 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Hoth Therapeutics, Inc. CENTRAL INDEX KEY: 0001711786 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 821553794 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 ROCKEFELLER PLAZA, SUITE 1039 CITY: NEW YORK STATE: NY ZIP: 10020 BUSINESS PHONE: 551-578-2261 MAIL ADDRESS: STREET 1: 1 ROCKEFELLER PLAZA, SUITE 1039 CITY: NEW YORK STATE: NY ZIP: 10020 4 1 ownership.xml X0306 4 2022-03-16 0 0001711786 Hoth Therapeutics, Inc. HOTH 0001751105 Sarnoff David C/O HOTH THERAPEUTICS, INC. 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020 1 0 0 0 Options 0.591 2022-03-16 4 A 0 40000 0 A 2022-03-16 2032-03-16 Common Stock 40000 40000 D The options were issued pursuant to the Issuer's 2018 Equity Incentive Plan and vested in full upon grant. /s/ Jane H. Springer as Attorney-In-Fact for David Sarnoff 2022-03-18